IPEX as a Result of Mutations in FOXP3

by van der Vliet, Hans J. J., Nieuwenhuis, Edward E.
Published 2007

CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond

by King, Lisa A., Lameris, Roeland, de Gruijl, Tanja D., van der Vliet, Hans J.
Published in Front Immunol (2018)

Corrigendum: CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond

by King, Lisa A., Lameris, Roeland, de Gruijl, Tanja D., van der Vliet, Hans J.
Published in Front Immunol (2018)

Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression

by Stolk, Dorian, van der Vliet, Hans J., de Gruijl, Tanja D., van Kooyk, Yvette, Exley, Mark A.
Published in Front Immunol (2018)

Hepatitis C Virus (HCV)-Specific CD8(+) Cells Produce Transforming Growth Factor β That Can Suppress HCV-Specific T-Cell Responses

by Alatrakchi, Nadia, Graham, Camilla S., van der Vliet, Hans J. J., Sherman, Kenneth E., Exley, Mark A., Koziel, Margaret James
Published 2007

Circulating Myeloid Dendritic Cells of Advanced Cancer Patients Result in Reduced Activation and a Biased Cytokine Profile in Invariant NKT Cells

by van der Vliet, Hans J. J., Wang, Ruojie, Yue, Simon C., Koon, Henry B., Balk, Steven P., Exley, Mark A.
Published 2008

Reversible posterior leukoencephalopathy syndrome during sunitinib therapy for metastatic renal cell carcinoma

by HADJ, JAMAL OULAD, BRAVEN, ROGIER DEN, TILLIER, CORRINE, SCHRIJVER, HANS M., VERHEUL, HENK M.W., VAN DER VLIET, HANS J.
Published 2012

The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments

by Veluchamy, John P., Kok, Nina, van der Vliet, Hans J., Verheul, Henk M. W., de Gruijl, Tanja D., Spanholtz, Jan
Published in Front Immunol (2017)

Irinotecan-Induced Dysarthria

by Dressel, Albertine J., van der Mijn, Johannes C., Aalders, IJke J., Rinkel, Rico N.P.M., van der Vliet, Hans J.
Published 2012

Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy

by Werter, Inge M., Schneiders, Famke L., Scotet, Emmanuel, Verheul, Henk M.W., de Gruijl, Tanja D., van der Vliet, Hans J.
Published in Oncoimmunology (2014)

Immunological effects of everolimus in patients with metastatic renal cell cancer

by Huijts, Charlotte M, Santegoets, Saskia J, de Jong, Tamarah D, Verheul, Henk M, de Gruijl, Tanja D, van der Vliet, Hans J
Published in Int J Immunopathol Pharmacol (2017)

Tumor Mutational Burden and Efficacy of Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

by Kim, Jong Yeob, Kronbichler, Andreas, Eisenhut, Michael, Hong, Sung Hwi, van der Vliet, Hans J., Kang, Jeonghyun, Shin, Jae Il, Gamerith, Gabriele
Published in Cancers (Basel) (2019)

Efficacy of Cancer Immunotherapy: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials

by Kim, Jong Yeob, Lee, Keum Hwa, Eisenhut, Michael, van der Vliet, Hans J., Kronbichler, Andreas, Jeong, Gwang Hun, Shin, Jae Il, Gamerith, Gabriele
Published in Cancers (Basel) (2019)

Statin and Cancer Mortality and Survival: An Umbrella Systematic Review and Meta-Analysis

by Jeong, Gwang Hun, Lee, Keum Hwa, Kim, Jong Yeob, Eisenhut, Michael, Kronbichler, Andreas, van der Vliet, Hans J., Shin, Jae Il, Gamerith, Gabriele
Published in J Clin Med (2020)

A Phase I Open‐Label Clinical Trial Evaluating the Therapeutic Vaccine hVEGF26–104/RFASE in Patients with Advanced Solid Malignancies

by Goedegebuure, Ruben S.A., Wentink, Madelon Q., van der Vliet, Hans J., Timmerman, Peter, Griffioen, Arjan W., de Gruijl, Tanja D., Verheul, Henk M.W.
Published in Oncologist (2020)

Standardized and flexible eight colour flow cytometry panels harmonized between different laboratories to study human NK cell phenotype and function

by Veluchamy, John P., Delso-Vallejo, María, Kok, Nina, Bohme, Fenna, Seggewiss-Bernhardt, Ruth, van der Vliet, Hans J., de Gruijl, Tanja D., Huppert, Volker, Spanholtz, Jan
Published in Sci Rep (2017)

Effect of Statin on Cancer Incidence: An Umbrella Systematic Review and Meta-Analysis

by Jeong, Gwang Hun, Lee, Keum Hwa, Kim, Jong Yeob, Eisenhut, Michael, Kronbichler, Andreas, van der Vliet, Hans J., Hong, Sung Hwi, Shin, Jae Il, Gamerith, Gabriele
Published in J Clin Med (2019)

Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer

by Veluchamy, John Pradeep, Spanholtz, Jan, Tordoir, Marleen, Thijssen, Victor L., Heideman, Daniëlle A. M., Verheul, Henk M. W., de Gruijl, Tanja D., van der Vliet, Hans J.
Published in PLoS One (2016)

Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer

by Huijts, Charlotte M, Santegoets, Saskia J, van den Eertwegh, Alfons J, Pijpers, Laura S, Haanen, John B, de Gruijl, Tanja D, Verheul, Henk M, van der Vliet, Hans J
Published 2011

Ex vivo Analysis of Resident Hepatic Pro-inflammatory CD1d-reactive T cells & Hepatocyte Surface CD1d Expression in Hepatitis C

by Yanagisawa, Kazuhiko, Yue, Simon, van der Vliet, Hans J., Wang, RuoJie, Alatrakchi, Nadia, Golden-Mason, Lucy, Schuppan, Detlef, Koziel, Margaret J., Rosen, Hugo R., Exley, Mark A.
Published 2013